ArticleBMC cancer2008

TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.

Michael D Oberst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.